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Background: The physiological processes in the cell are regulated by reversible, electrostatic protein-protein
interactions. Apoptosis is such a regulated process, which is critically important in tissue homeostasis and
development and leads to complete disintegration of the cell. Pathological apoptosis, a process similar to
apoptosis, is associated with aging and infection. The current study shows that pathological apoptosis is a process
caused by the covalent interactions between the signaling proteins, and a characteristic of this pathological
network is the covalent binding of calmodulin to regulatory sequences.
Results: Small molecules able to bind covalently to the amino group of lysine, histidine, arginine, or glutamine
modify the regulatory sequences of the proteins. The present study analyzed the interaction of calmodulin with
the BH3 sequence of Bax, and the calmodulin-binding sequence of myristoylated alanine-rich C-kinase substrate in
the presence of xanthurenic acid in primary retinal epithelium cell cultures and murine epithelial fibroblast cell
lines transformed with SV40 (wild type [WT], Bid knockout [Bid-/-], and Bax-/-/Bak-/- double knockout [DKO]). Cell
death was observed to be associated with the covalent binding of calmodulin, in parallel, to the regulatory
sequences of proteins. Xanthurenic acid is known to activate caspase-3 in primary cell cultures, and the results
showed that this activation is also observed in WT and Bid-/- cells, but not in DKO cells. However, DKO cells were
not protected against death, but high rates of cell death occurred by detachment.
Conclusions: The results showed that small molecules modify the basic amino acids in the regulatory sequences
of proteins leading to covalent interactions between the modified sequences (e.g., calmodulin to calmodulin-
binding sites). The formation of these polymers (aggregates) leads to an unregulated and, consequently,
pathological protein network. The results suggest a mechanism for the involvement of small molecules in disease
development. In the knockout cells, incorrect interactions between proteins were observed without the protein
modification by small molecules, indicating the abnormality of the protein network in the transgenic system. The
irreversible protein-protein interactions lead to protein aggregation and cell degeneration, which are observed in
all aging-associated diseases.
Background
Cell degeneration is observed in all aging- and infection-
associated pathologies. Currently, the same process of
apoptosis is considered to occur in tissue homeostasis
and development, as well as in diseases. The current
understanding suggests that too little apoptosis leads to
cancer and too much apoptosis leads to degenerative
diseases. Consequently, cancers are treated with small
molecules to induce apoptosis; however, prolonged use
of small molecules also leads to cancer [1].
This understanding of apoptosis in disease develop-
ment did not give a solution for the treatment of degen-
erative diseases and led to very toxic methods in cancer
therapeutics. The understanding of apoptosis is a key
issue for further research.
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ciated diseases by inhibiting the caspases. The failure of
this approach indicates that cell degeneration cannot be
stopped by inhibition of the end-enzyme caspase. There-
fore, an upstream event is responsible for cell degenera-
tive disorders.
Knowledge of the mechanism associated with patholo-
gical apoptosis is necessary to stop aging-associated
degeneration, which is a feature of aging-associated
pathologies. The lesson from cancer showed that treat-
ment with small molecules leads to degenerative dis-
eases in other organs. The cells do not disappear, but
protein aggregates are formed leading to complications
in the therapy, such as thrombosis and kidney degenera-
tion [2-5].
Aging-associated degeneration is accelerated with
pollution. Reactive oxygen species (ROS) caused by pol-
lution have been reported as a major factor for degen-
erative diseases [6]. Oxidative stress has been considered
for years as a cause of diseases. Oxidative stress leads to
induction of indoleamine-2,3-dioxygenase and produc-
tion of kynurenines and the end product xanthurenic
acid [7]. The fluorescence of the lens proteins has been
used for cataract diagnosis since the 19th century. Thus,
small molecules are a very important factor leading to
degenerative diseases. Degenerative diseases are asso-
ciated with aging, indicating accumulation of the
changes caused by small molecules.
The current study showed that small molecules, such
as xanthurenic acid modifying the regulatory sequences
of proteins, lead to stable interactions between proteins
and a new pathological network, which we called
misfoldome.
Xanthurenic acid, an endogenous substance formed
from tryptophan, is the small molecule in this cell cul-
ture model of disease development by posttranscrip-
tional modification of the proteins in neuromodulation
[8], but its covalent binding with proteins leads to cell
death [9]. Exposure to xanthurenic acid at concentra-
tions of 10 μM or higher for more than 72 hours has
been observed to lead to pathological apoptosis [10] and
oxidative stress [11,12]. It has previously been reported
that xanthurenic acid accumulates in senile cataract
[13], leading to an unfolded protein response [9]. Nor-
mal physiological apoptosis is a regulated process based
on a network of reversible interactions between proteins,
called interactome. The basic requirement for this pro-
tein network is the regulated interactions between pro-
teins. The flexible interactions maintain cell physiology.
Xanthurenic acid forms an oxidative derivative, an
amino-quinone [14,15], and the quinone radicals react
with the amine group of proteins. This chemical reac-
tion could be responsible for the modification of pro-
teins in a time- and concentration-dependent manner,
leading to aging-associated diseases. The misfolded pro-
teins change their place and role in the cells, leading to
irreversible pathological apoptosis, mitochondrial
damage, interruption of calcium homeostasis, and trans-
location of the signaling protein 14-3-3 into lysosomes
[10-12,16]. Pathological apoptosis is induced through
the mitochondrial pathway, which involves translocation
of the BH3-only proapoptotic proteins into the mito-
chondrial membrane, leading to caspase-3 activation.
The interaction of 14-3-3 with phosphorylated Bad is
interrupted, leading to Bad dephosphorylation and
translocation into mitochondria. These events were also
described for apoptosis; however, in pathological apop-
tosis, they are not regulated, leading to a constitutive
degenerative process.
The present study shows that the covalent modifica-
tions of proteins by xanthurenic acid lead to covalent,
and subsequently nonregulated, interactions of calmodu-
lin with the binding sites regulated by calmodulin and/
or phosphatidylinositol-4,5-phosphate, such as the effec-
tor domain (ED) sequence of myristoylated alanine-rich
C-kinase substrate (MARCKS) and BH3 of Bax. The
covalent interactions between signaling proteins, such as
calmodulin and the calmodulin-binding sites of the pro-
teins, abolish tissue homeostasis. The new, stable signal-
i n go ft h en e t w o r ko fc a l m o d u l i n - b i n d i n gp r o t e i n s ,
which regulate hundreds of proteins, leads to many




N-tert-Butyloxycarbonyl-amino acids (Boc-amino acids),
xanthurenic acid, and other chemicals were purchased
from Sigma (Buchs, Switzerland), and the peptides were
synthesized by Virusys (USA). The rabbit polyclonal anti-
bodies against the peptides, modified in vitro,w e r e
prepared at the University of Zurich (Switzerland). Anti-
bodies against PARP, caspase-3, the N-terminal part of
Bax, calmodulin, and rabbit secondary IgG were from
Santa Cruz Biotechnology Inc. (Santa Barbara, CA, USA);
phospho-Bad Ser136 was from Cell Signaling Technology
I n c .( D a n v e r s ,M A ,U S A ) .M i t o t r a c k e rC M X R o sw a s
from Molecular Probes (Leiden, The Netherlands).
Cell culture
Primary cell cultures of human retinal epithelial cells
(RPE) were prepared and cultivated as previously
described [11]. Murine embryonic fibroblast (MEF) cell
lines, wild type (WT), Bid knockout (Bid-/-), and
Bax-/-/Bak-/- double knockout (DKO), were provided
by Dr. S. J. Korsmeyer (Harvard Medical School, USA).
The cell cultures were cultivated in MEM from Invitro-
gen (Basel, Switzerland).
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The cell extracts were mixed with the antibody at a con-
centration of 10 μg/mL overnight at 4°C, and the immu-
noprecipitated proteins were separated on SDS-PAGE
gel. The proteins were detected by western blot analysis
with the appropriate antibodies.
Western blot analysis
Control cells and cells from the cell culture in the pre-
sence of increasing concentrations of xanthurenic acid
(5, 10, and 20 μM of medium) were allowed to grow in
parallel in a 750-mL flask. The cells were washed in PBS
and lysed in 50 mM Tris-Cl (pH 8), 150 mM NaCl, 1%
Triton X-100, and the following protease inhibitors:
0.1 mM phenyl-methylsulfonyl fluoride and 1 μg/mL
each of leupeptin, pepstatin and aprotinin. Then, the
sample was centrifuged for 10 min at 14,000g,a n dt h e
supernatant was boiled in loading buffer for 5 min. Pro-
teins at 100 μg per lane were separated by SDS-PAGE
containing 12.5% acrylamide. The proteins, after being
transferred to Hybond, were probed with the appropri-
ate antibodies. The chemiluminescence ECL system
(Amersham Pharmacia Biotech AB, Uppsala, Sweden)
was used for the detection of peroxidase-conjugated sec-
ondary antibody. Xanthurenic acid induced pathological
apoptosis, leading to degradation of the cell proteins
with parallel aggregation of the basic protein sequences.
The same global quantities of proteins in the cell
extracts were compared. Loading with proteins known
to be degraded during apoptosis, such as actin, will lead
to interpretation errors.
Immunofluorescence studies
Cells grown on glass coverslips were fixed for 10 min at
room temperature in 4% paraformaldehyde in 0.1 M PIPES
(pH 6.8), washed in PBS, and permeabilized for 5 min in
PIPES containing 0.05% saponin (65 μL per coverslip). The
cells were then washed in PBS, incubated for 10 min in
cold acetone for additional fixing and permeabilization,
and again washed in PBS. The cells were incubated for
1.5 h with the first antibody diluted in PBS containing 1%
bovine serum albumin, and after further washing, the cells
were incubated for 1.5 h with the secondary antibody. The
coverslips were washed in PBS and incubated for 10 min
with 65 μL of solution containing 1 mL of Hoechst 33342
dye (1 mg/mL), washed in PBS, and incubated with Anti-
fade Kit (Molecular Probes, Leiden, the Netherlands)
according to the supplier’s instructions. Mitotracker was
used as previously described [11].
Microscopy
Confocal microscopy was done with a Zeiss 410 laser
scanning microscope (Department of Clinical Research,
University of Bern, Switzerland).
Results
Xanthurenic acid modifies the Boc-amino acids lysine,
arginine, histidine, and glutamine
The Boc modification of amino acids blocks its primary
amino group, and the secondary amino group of amino
acids remains free from modification. The Boc-amino
acids lysine, arginine, histidine, and glutamine were
observed to bind covalently with fluorescent xanthurenic
acid. The covalently modified, fluorescent amino acids
were separated by thin layer chromatography. The result
showed that a reaction between xanthurenic acid and
Boc-amino acid occurs on the secondary groups of
amino acids and is dependent on xanthurenic acid
concentration and incubation time. Consequently, the
amino groups in proteins and peptides are modified by
xanthurenic acid, leading to their polymerization. Cova-
lent cross-linking of polylysine, for example, was observed
on SDS-PAGE gels after incubation with xanthurenic
acid. The chemical reaction of the covalent modification
of the proteins by xanthurenic acid occurs in cell culture
in vitro, leading to fluorescent proteins. Xanthurenic acid
is an endogenous substance, and the modification of the
proteins in vivo leads to accumulation of the modified,
fluorescent proteins, as observed in pathological tissues
such as the cataract lens. The proteins modified cova-
lently by small molecules on the secondary amino group
of amino acids became stably misfolded and insoluble.
The modification occurs in random on 1 or several
amino acids, making the establishment of the structure of
the modified protein difficult or impossible. However,
knowledge of the protein structure after modification,
which could be of interest to chemists, has less
importance for cell biologists and drug development
researchers. In this study, the relevant fact is that the
modification leads to stable protein-protein interactions
inducing nonregulated signaling. The network, which
cannot be further regulated, leads to cell pathology.
Cell death in the presence of xanthurenic acid in MEF
cell lines
Xanthurenic acid induced apoptotic cell death in MEF
cells (Figure 1). Cell death was caspase-3 and PARP
dependent in WT MEF cells. Caspase-3 and PARP were
not activated by xanthurenic acid in DKO cells, but in
Bid-/- cells, an activation of PARP and caspase-3 was
observed (Figure 2A,B). Thus, Bax and Bak are essential
for the induction of caspase-3 in the presence of
xanthurenic acid in cell lines transformed with SV40.
However, the lack of proapoptotic proteins in the Bax/
Bak double knockout did not rescue the cells from death
in the presence of xanthurenic acid; cell death occurred
by massive detachment. This indicates that xanthurenic
acid leads to activation of an upstream target common
for caspase-3 activation and cell detachment.
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acid cell culture model
It was of interest to determine the covalent protein-
protein interactions leading to pathological apoptosis and
to establish the conditions necessary for the covalent
modification of the proteins in the cell leading to protein
polymerization. The xanthurenic acid in the primary cell
culture was used as a model of cell pathology develop-
ment in the presence of small molecules. We studied the
mechanism of pathological apoptosis in the presence of
xanthurenic acid in the RPE primary cell culture and the
cell culture of MEF cell lines transformed with SV40. In
cell culture with 10 μM xanthurenic acid, the covalent
modification of the proteins began after 72 h. In the
same conditions, the covalent interactions, clearly detect-
able by western blot, were observed after 96-120 h. The
120-hour cell culture was then used, in which the cova-
lent interactions were easily detectable.
Absence of Bad protein dephosphorylation in MEF cell
lines transformed with SV40 in the presence of
xanthurenic acid
Previously, it has been reported that Bad is dephosphory-
lated with 10 μM xanthurenic acid and translocated into
mitochondria in primary astrocytes in the presence of
xanthurenic acid [16]. In this study, Bad was analyzed in
MEF cell cultures (WT, Bid-/-, and DKO). Bad interac-
tion with 14-3-3 proteins prevents apoptosis, and phos-
phorylation of Bad Ser136 is crucial for its binding to
14-3-3 [17]. Western blot analysis of the WT, Bid-/-, and
DKO protein extracts from control cells and cells grow-
ing in the presence of 10 and 20 μM xanthurenic acid
showed that phospho-Bad Ser136 was not dephosphory-
lated in these cell lines in the presence of xanthurenic
acid (Figure 3). This indicates that Bad does not play a
role in the induction of apoptosis in these cells trans-
formed with SV40 (Figure 3). The study also indicates
that the results obtained in a cell line are different from
those obtained in a primary cell culture, which mimics
the conditions in the normal mammalian tissue.
Covalent interaction of MARCKS with
calmodulin in Bid-/- and DKO MEF cells
The proteins were immunoprecipitated from extracts of
MEF cell lines (WT, Bid-/-, and DKO) with an antibody
against calmodulin (Figure 4) Western blot analysis was
used to investigate the binding of calmodulin to
MARCKS proteins. Calmodulin interactions with the
basic sequence of the ED of MARCKS became covalent
in the presence of xanthurenic acid, but they were differ-
ent in the knockout cells in comparison to WT cells. The
ED of MARCKS is an example of a lysine-rich regulatory
sequence. The ED binds calmodulin electrostatically.
MARCKS with bound calmodulin is translocated
to acidic membranes and cannot be phosphorylated by
protein kinase C [18]. Calmodulin trapped by MAR-
CKS cannot participate in the numerous calmodulin
functions [18].
We now report that in the presence of xanthurenic
acid, calmodulin binds covalently to the ED sequence of
Figure 1 MEF cell lines death, WT, Bid -/- and DKO, in the
presence of xanthurenic acid (Xan): (A, B, C)- wide type; (D, E, F)
-Bid-/-; (G, H, I)- DKO. (A, D, G)- control; (B, E, H)-10 μM Xan; (C, F, I)
-20 μM Xan.
Figure 2 MEF cell line, BID -/-: activation of PARP and caspase
3 in the presence of 10 μM of xanthurenic acid: upper photos
the cells without xanthurenic acid and bottom photos with 10 μM
of xanthurenic acid: left (upper-down) detection of PARP, right
(upper-down) detection of caspase-3.
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cells were used. The interaction between calmodulin and
the ED sequence of MARCKS in these cells was investi-
gated. Cell extracts from the MEF cells, WT, Bid-/-, and
DKO from control cells and cells grown with 10 and
20 μM xanthurenic acid, were immunoprecipitated with
calmodulin. The immunoprecipitated proteins were ana-
l y z e db yw e s t e r nb l o tw i t ha n t i b o d ya g a i n s tt h eE D
domain of MARCKS (KKKKKRFSFKKSFKLSGFSFK
KKNKK). Calmodulin did not bind covalently MARCKS
in control cells. However, in the presence of 10 and 20
μM xanthurenic acid, covalent crosslinking of calmodulin
with MARCKS occurred.
In the presence of xanthurenic acid, the small protein
calmodulin (18.6 kDa) binds covalently to the ED
sequence of the degraded MARCKS and forms numerous
polymers. The results showed that the protein aggrega-
tion takes place despite cell degeneration (Figure 1).
Calmodulin forms stable polymers with the calmodulin-
binding sites of MARCKS, which are not degraded by
cell death-associated proteases but form aggregates.
The western blot showed that the polymers were better
d e t e c t a b l ei nt h ep r e s e n c eo f1 0μMc o m p a r e dw i t h
20 μM xanthurenic acid. This result suggests that with a
higher concentration of xanthurenic acid, the polymers
formed aggregates with other proteins, becoming partly
insoluble and not present in the cell-free extract and/or
less accessible for binding with calmodulin.
In the same cells, the interaction of MARCKS with
calmodulin was completely different between the Bid-/-
and DKO genotypes. In double-mutant cells (DKO),
MARCKS bound calmodulin in control cells and in the
presence of 10 μM xanthurenic acid, but this interaction
was abolished at 20 μM xanthurenic acid. In Bid-/-
cells, the MARCKS-calmodulin covalent interaction was
not detected.
The results indicate that xanthurenic acid abolishes
the regulation of cell physiology by generating covalent
interactions between proteins. The protein-protein inter-
actions in knockout cells are different from those in WT
cells. The results suggest that it would be inappropriate
to use knockout animal models to study the develop-
ment of aging-associated disease processes or drugs
against metabolic diseases, such as atherosclerosis,
Alzheimer’s disease, Parkinson’s disease, retinal degen-
eration etc., because the protein-protein interactions can
be different from those in aging mammalian having the
posttranscriptionally modified proteins.
Xanthurenic acid interrupts BH3 interaction with 14-3-3
and causes new covalent Bax-calmodulin interactions in
the primary cell culture of RPE translocated to the
mitochondrial membrane
It was previously reported that Bax in the cytoplasm
binds 14-3-3-θ protein, and an interruption of this non-
covalent binding leads to Bax translocation into mito-
chondria [19]. An antibody was prepared against the
BH3 sequence -KKLSECLKR- of Bax polymerized with
xanthurenic acid, but without conjugation with another
protein, then specific only for the BH3 sequence of Bax.
Anti-calmodulin antibody was used for the precipitation
of protein extracts from retinal pigment epithelium pri-
mary cell cultures and cultures grown in the presence of
xanthurenic acid. Western blot analysis of the immuno-
precipitated proteins showed a band of 37 kDa, which
reacts with the anti-BH3 sequence of Bax. This indicates
that Bax and calmodulin are covalently bound in the
presence of xanthurenic acid (Figure 5).
Confocal microscopy showed that the BH3 sequence
in the presence of 10 μM xanthurenic acid was detected
in mitochondria (Figure 6A); at 20 μM xanthurenic acid,
the BH3 sequence was not further translocated into the
nucleus but colocalized in the mitochondrial membrane
(Figure 6B). Bax, in the absence of xanthurenic acid was
in cytoplasm, as detected with the same antibody anti-N
Figure 3 Western blot analysis of pBad immunoprecipitated with
14-3-3 in MEF cells: WT, Bid -/- and DKO: WT lanes 1-3; 1-control,
lanes (2-3) in the presence of xanthurenic acid: lane 2-10 μM, lane
3- 20 μM; Bid -/-: lane 4-control, lanes (5-6) in the presence of
xanthurenic acid: lane 5-10 μM, lane 6- 20 μM; DKO lanes 7-9; lane
7-control, lanes (8-9) in the presence of xanthurenic acid: lane
8-10 μM, lane 9- 20 μM.
Figure 4 Interaction of calmodulin-binding site of MARCKS with
calmodulin (CAM) in the presence of xanthurenic acid in MEF
cells WT, Bid -/- and DKO. Western blot analysis with antibody
against ED sequence of MARCKS of proteins immunoprecipitated
with CAM: WT lanes1-3, lane 1-control, lanes (2-3) in the presence of
xanthurenic acid: lane 2-10 μM, lane 3- 20 μM; Bid -/- lanes 4-6: lane
4-control, lanes (5-6) in the presence of xanthurenic acid: lane
5-10 μM, lane 6- 20 μM; DKO lanes 7-9; lane 7-control, lanes (8-9) in
the presence of xanthurenic acid: lane 8-10 μM, lane 9- 20 μM.
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Malina et al. [12]. However, in the presence of 20 μM
xanthurenic acid the N-terminal part of Bax colocalized
in the nucleus (Figure 6C). It suggests stable binding of
at least a part of this N-terminal sequence to an
unknown nuclear protein, RNA, or DNA. In this study,
we showed, using an antibody against the anti-BH3 pep-
tide of Bax, that the BH3 sequence was not further
degraded or translocated into the nucleus. The BH3
sequence is polymerized with calmodulin at 20 μM
xanthurenic acid (Figure 5) and colocalized in the mito-
chondrial membrane despite cell death, destruction of
mitochondria and mitochondrial membrane polymeriza-
tion (Mitotracker-red staining) (Figure 6C).
We consider that the BH3 sequence bound to calmo-
dulin in the presence of xanthurenic acid is covalently
inserted into the mitochondrial membrane, leading to
constitutive activation of caspase-9 and caspase-3 and
destruction of mitochondria [11,12].
Discussion
Epidemiological studies show that small molecules are
associated with disease development. Many programs of
disease prevention indicate that cigarette smoking and
air pollution should be avoided to prevent diseases
[20-22]. However, the mechanism of the pathology
induced by small molecules has not been reported.
Many diseases are associated with aging, suggesting that
a posttranscriptional modification, developed over the
life span, may be an essential factor. Covalent attach-
ment of small molecules to proteins changes the protein
folding, and the proteins become stably modified by the
small molecules.
The terms “misfolded” or “unfolded” proteins are
currently used interchangeably for the stably modified pro-
teins or transiently modified proteins, making communi-
cation difficult between researchers in the field. Misfolded
proteins need a clearer definition to permit progress in the
understanding of disease development by the posttran-
scriptional mechanism. We propose to define “misfolded
proteins” as stably modified proteins and “unfolded pro-
teins” as transiently or reversibly modified proteins, and
these definitions were used throughout this paper. In the
current study, misfolded proteins are covalently and irre-
versibly modified by a small molecule, leading to a stable
interaction between the protei n s .T h es t a b l ei n t e r a c t i o n
occurs usually between the regulatory sequences and leads
to erroneous signaling resulting in cell pathology.
We observed that the covalent modification of the pro-
teins by small molecules is the mechanism of formation
of a new covalent network in pathological apoptosis. The
primary modification of the proteins preferentially occurs
in the presence of substances that have or generate qui-
none-like structures. The upstream modifications are fol-
lowed by mitochondrial damage and the attachment of
simple carbonyls or lipids to the proteins under oxidative
stress.
These quinones lead to enzyme-free crosslinking with
the basic amino acids [23], as observed in the presence of
xanthurenic acid [9]. Many substances inducing oxidative
stress, such as MPTP [24] or streptozotocin, lead to acti-
vation of indoleamine-2,3-dioxygenase (IDO) via oxidative
stress and formation of kynurenines [25]. Then, a primary
cell culture in the presence of xanthurenic acid is a good
model to study the pathology associated with a posttran-
scriptional modification of proteins.
The increase in the incidence of metabolic diseases
with aging is consistent with the observation in cell cul-
ture, in which the irreversible modifications of the pro-
teins by small molecules are dependent on the time of
incubation and the concentration of small molecules in
the cell culture. The small molecule, xanthurenic acid, is
formed from tryptophan during oxidative stress due to
activation of IDO. IDO is increased in many degenerative
disorders such as cancer, immunosuppressive diseases,
and infectious diseases [26-29]. IDO overexpression is
induced by emotional stress, IFN-g, and oxidative stress
[8,30,31]. However, IDO scavenges oxygen radicals, which
are known to play a role in disease development [7,32].
Tryptophan degradation by IDO leads to production of
Figure 5 Binding of calmodulin (CAM) to BH3 sequence of Bax
in the presence of xanthurenic acid in the primary human cell
culture of the human retinal epithelial cells: Western blot
analysis with antibody against BH3 of proteins immunoprecipitated
with CAM, lane 1-control, lanes (2-4) in the presence of xanthurenic
acid: lane 2-5 μM, lane 3-10 μM, lane 4- 20 μM.
Figure 6 Primary cell culture of the human retinal epithelial
cells: localization of BH3 sequence in the presence of
xanthurenic acid: (A) BH3 sequence (green) in the presence of
10 μM xanthurenic acid, (B) NH2-terminal sequence (green) in the
presence of 20 μM xanthurenic acid is translocated to nucleus,
Mitotracker (red) shown polymerization of mitochondrial
membranes, (C) mitochondria (yellow): co-localization of BH3-
sequence (green) in presence of 20 μM xanthurenic acid and with
Mitotracker (red).
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enine aminotransferase (KAT) is the enzyme leading to
the alternative pathway of xanthurenic acid formation.
KAT also has allosteric enzymatic activity for glutaminase
K and cystathionine-b-lyase [33,34]. The best inhibitor of
KAT thus far is isonicotinic acid hydrazide, which is used
for the treatment of tuberculosis [35]. Xanthurenic acid
has been reported in pathological conditions such as
infection [36], Crohn’s disease [30], cataract [13], and
depression and anxiety [37,38]. Previously, xanthurenic
acid, the endogenous substance affecting protein folding,
was reported to lead to pathological apoptosis [10]. HIV
infection, causing AIDS, is an in vivo proof of the devel-
opment of aging-associated disease due to infection and
subsequent induction of IDO [39]. IFN-g and ROS are
widely proven stimulators of the inducible enzyme IDO
[30]. Oxidative stress leads to lysosomal modification,
which leads to lysosomal storage diseases [40,41]. Lysoso-
mal modification is observed in astrocytes in the presence
of xanthurenic acid [16]. Mitochondrial damage and oxi-
dative stress are largely observed in aging-associated car-
diovascular diseases. Xanthurenic acid induces
pathological apoptosis through mitochondrial damage via
irreversible Bax insertion into the mitochondrial mem-
brane, as shown in this study and in previous reports
[12]. An increase in xanthurenic acid was reported in cat-
aract [42], in diabetes [43], and oxidative stress was
observed in diseases of the central nervous system [44].
Our previous studies showed that xanthurenic acid
leads to covalent modification of the proteins. Any sub-
stance able to react with the regulatory sequences, cor-
responding to the intrinsic disorder sequences, which
are responsible for the protein-protein interactions,
abolishes physiological regulation and leads to metabolic
disorders. The substances can be provided by small-
molecule drugs, environmental toxins, cigarette smoke
etc. The mammalian body does not have enzymes that
can remove such modifications, and the modified
sequences accumulate during the life span. Small mole-
cules, able to react covalently with at least 2 secondary
groups of amino acids of the regulatory basic sequences,
lead to their polymerization. The incidence of metabolic
diseases increases with aging, which is consistent with
the observation in cell culture that the irreversible modi-
fications of the proteins by the small molecules are
dependent on the time of incubation and the concentra-
tion of the small molecules in cell culture. The small
molecule xanthurenic acid is the model molecule for the
formation of the network of misfolded proteins, called
misfoldome, in the cell culture model.
The current study showed that in the cell line trans-
formed with SV40, Bad was not proapoptotic, but Bax/
Bak was necessary for caspase-3 activation in the pre-
sence of xanthurenic acid. In the primary retinal cell
culture (RPE), Bax polymerized with calmodulin in the
presence of xanthurenic acid. Moreover, the BH3
sequence of Bax modified by xanthurenic acid was spe-
cifically translocated to the mitochondrial membrane in
the degenerating cells. Such a protein polymerization
leads to a nonregulated translocation of Bax and irrever-
sible mitochondrial damage. However, the lack of Bax/
Bak leads to another heavy pathology-cell detachment.
Xanthurenic acid in the cell cultures leads to the cova-
lent interaction of Bax or MARCKS with calmodulin.
However, this interaction was different in the WT cell
line compared to the knockout cells.
Conclusions
This study reports that pathological apoptosis is asso-
ciated with a posttranscriptional modification of the reg-
ulatory sequences. New protein-protein interactions
were observed-the covalent interactions of calmodulin
with calmodulin-binding sites. In a primary cell culture
or in a cell culture transformed by SV40, the new,
incorrect covalent protein-protein interactions occur
when the regulatory sequences are modified by
xanthurenic acid. The covalent binding of calmodulin to
the regulatory sequences is a characteristic of this new
covalent and pathological network.
However, in the transgenic cell lines, which are used
frequently to study disease development, the protein-
protein interactions were completely different from
those in WT cell lines. Moreover, the interactions are
different between a cell line and a primary cell culture.
These results show that it is impossible to study a dis-
ease that develops by posttranscriptional modification of
the proteins, such as aging-associated diseases or infec-
tions, in a transgenic animal model because the protein-
protein interactions in the transgenic cells are different
from those in the WT cells. There have been many stu-
dies on protein-protein interactions in transgenic cells
or animals, and the models are used for drug develop-
ment. The present study shows that the protein-protein
interactions in transgenic or immortalized cells are dif-
ferent from those in the wild- type organism.
The new interactions between the covalently modified
proteins establish a covalent network of proteins, which
lead to the metabolic disorder, called pathological apop-
tosis. The hallmark of this new protein network is the
covalent binding of calmodulin to calmodulin-binding
sites. Therefore, a condition leading to the nonphysiolo-
gical covalent interactions of the proteins leads to tissue
pathology, such as the nonregulated apoptosis observed
in all degenerative diseases. The process of degeneration
will begin earlier in the life span if there was increased
exposure to small molecules, which accumulate due to
oxidative stress associated with infection, emotional
stress, air pollution, dietary intake of proteins from
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cigarette smoke, or drug use. The modifications can
occur in any cell and consequently lead to organ
degeneration.
We used the term “unfolded protein” for proteins with
transiently changed folding in the maturation process or
in a post-transcriptional reversible process such as phos-
phorylation, methylation etc. These proteins are comple-
tely degraded in the protein turnover process. However,
t h ep r o t e i n st h a tw et e r m e d“misfolded” are covalently
and irreversibly modified by small molecule, such as
xanthurenic acid, and alter physiological protein-protein
interactions. These molecules cause the covalent pro-
tein-protein interactions. Such interactions are stable
then are nonregulated, and are responsible for the cell
pathology. The polymerized sequences are not removed
from the cell, but lead to permanent signaling for cell
apoptosis, resulting in the degeneration of the cell but
not to degradation of the modified sequences, which
form the protein aggregates ("plaques”)o b s e r v e di n
degenerative diseases.
We conclude that aging-associated diseases develop by
posttranscriptional covalent modification of the regula-
tory sequences modified by small molecules. Xanthure-
nic acid in a primary cell culture is a model showing
results corresponding with the situation in vivo.T h e
xanthurenic acid in the primary cell culture model
mimics the changes of the protein-protein interactions
in vivo, which lead to disease.
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